BIOLOGY.DIGITAL
Back to Glossary

Organ-on-Chip Microphysiological Systems

Acronym for: OoC / MPS

Also known as: Human Liver-Chip / Lung-Chip, Microfluidic Vascularized Organoids, FDA Modernization Act 2.0 NAMs

Perfused microfluidic cell-culture devices lined with living primary or iPSC-derived human parenchymal cells, endothelial vasculature, and immune cells that recapitulate organ-level mechanical forces (fluid shear stress, cyclic breathing stretch) and human metabolic toxicity in vitro.

**Quick Spec:** - Term: Organ-on-Chip Microphysiological Systems - Standard: OoC / MPS - Where you'll use it in your R&D stack: Preclinical Safety & Toxicology, Translational Pharmacology, Non-Animal New Approach Methodologies (NAMs) - Platforms we've benchmarked for our readers: Emulate, MIMETAS, CN Bio Innovations

Architectural Role in Modern Life Science R&D

Over 89% of drugs that pass preclinical rodent, canine, and non-human primate toxicology studies still fail in human clinical trials, with drug-induced liver injury (DILI) and cardiotoxicity representing top causes of late-stage attrition. Following the passage of the US FDA Modernization Act 2.0 (which removed the statutory mandate for animal testing prior to human trials) and the 2024 FDA ISTAND qualification program, pharmaceutical teams pair Organ-on-Chip Microphysiological Systems (from Emulate, MIMETAS, CN Bio, and Hesperos) with computational PK/PD modeling to screen human-specific hepatotoxicity, blood-brain barrier penetration, and ADCC immunotherapy efficacy. Why does this matter for your lab? If you're scaling Organ-on-Chip Microphysiological Systems in production, we've found you can't treat it as a black box. You'll need tight wet-lab calibration, and we always recommend validating your pipeline against orthogonal assays before you lock in your budget.

Evaluation & Wet-Lab Integration Checklist

How do you evaluate Organ-on-Chip Microphysiological Systems without wasting six months? Start small. When we audit R&D informatics teams, we tell you to test three things first: prospective wet-lab accuracy (like SPR or Cryo-EM), native API sync with your ELN, and containerized GPU costs. Don't skip the retrospective benchmark. It's the fastest way to see if a vendor's model actually works on your proprietary targets.

Context

Over 89% of drugs that pass preclinical rodent, canine, and non-human primate toxicology studies still fail in human clinical trials, with drug-induced liver injury (DILI) and cardiotoxicity representing top causes of late-stage attrition. Following the passage of the US FDA Modernization Act 2.0 (which removed the statutory mandate for animal testing prior to human trials) and the 2024 FDA ISTAND qualification program, pharmaceutical teams pair Organ-on-Chip Microphysiological Systems (from Emulate, MIMETAS, CN Bio, and Hesperos) with computational PK/PD modeling to screen human-specific hepatotoxicity, blood-brain barrier penetration, and ADCC immunotherapy efficacy. Why does this matter for your lab? If you're scaling Organ-on-Chip Microphysiological Systems in production, we've found you can't treat it as a black box. You'll need tight wet-lab calibration, and we always recommend validating your pipeline against orthogonal assays before you lock in your budget.

Examples

  • 1Emulate Human Liver-Chip benchmarking 27 known hepatotoxic and non-toxic small molecules with 87% sensitivity and 100% specificity, catching toxicities missed in preclinical animal models.
  • 2Using MIMETAS OrganoPlate high-throughput 384-well microfluidic arrays to screen antibody-drug conjugate (ADC) vascular extravasation across 3D human tumor-vessel barriers.
  • 3Connecting multi-organ liver, cardiac, and skeletal muscle chips (Hesperos) to measure parent drug and liver metabolite cardiotoxicity in a single recirculating serum-free medium.

Implementing Agents

AI agents that implement or utilize Organ-on-Chip Microphysiological Systems:

Common Industries

Preclinical Safety & ToxicologyTranslational PharmacologyNon-Animal New Approach Methodologies (NAMs)

Related Terms

Learn More

Verified References & Citations (2)

  1. [1]

    Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology across 870 chips.

  2. [2]

    FDA accepts first Organ-on-Chip microphysiological system into the ISTAND Qualification Program for drug development tools.

Last updated: March 1, 2026

Ask AI